Cargando…

Recent advances in the management of gastric adenocarcinoma patients

Gastric adenocarcinomas are a significant cause of cancer and cancer death, globally. The curative approach for those with diagnosed localized disease is with surgical resection and an adjunctive approach of perioperative chemotherapy, postoperative adjuvant therapy, or postoperative chemoradiation....

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogers, Jane E, Ajani, Jaffer A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty Opinions Ltd 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975945/ https://www.ncbi.nlm.nih.gov/pubmed/36873983 http://dx.doi.org/10.12703/r/12-2

Ejemplares similares

Recent advances in the management of gastric adenocarcinoma patients
por: Harada, Kazuto, et al.
Publicado: (2018)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

Recent advances in treating oesophageal cancer
por: Harada, Kazuto, et al.
Publicado: (2020)

Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
por: Rogers, Jane E., et al.
Publicado: (2023)

Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy
por: Badgwell, Brian, et al.
Publicado: (2017)

Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018)

Therapeutic Advances in the Treatment of Gastroesophageal Cancers
por: Li, Jenny J., et al.
Publicado: (2023)

Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
por: Cen, Putao, et al.
Publicado: (2008)

Can You Establish the Cause of This Patient's Shortness of Breath?
por: Trail, Allison, et al.
Publicado: (2023)

Review of docetaxel in the treatment of gastric cancer
por: Tetzlaff, Eric D, et al.
Publicado: (2008)

Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors
por: Rogers, Jane E., et al.
Publicado: (2022)

Targeted literature review of the global burden of gastric cancer
por: Casamayor, Montserrat, et al.
Publicado: (2018)

Can We Understand the Clinical Biology of Gastric Cancer and Exploit it? May be, but It is a Challenge!
por: Ajani, Jaffer A.
Publicado: (2007)

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective
por: Xu, Yan, et al.
Publicado: (2019)

Recent advances in endoscopic management of gastric neoplasms
por: Cheema, Hira Imad, et al.
Publicado: (2023)

Proteomic profiling of key signatures from gastric lesions to early gastric cancer
por: Fan, Yibo, et al.
Publicado: (2021)

Customization of therapy for gastroesophageal adenocarcinoma patients
por: Mizrak Kaya, Dilsa, et al.
Publicado: (2018)

Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma
por: Allen, Casey J., et al.
Publicado: (2020)

Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer
por: Haque, Emaan, et al.
Publicado: (2022)

Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)
por: Shah, Manish A., et al.
Publicado: (2021)

Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response
por: Abdelhakeem, Ahmed A., et al.
Publicado: (2021)

Treatment of Gastric Adenocarcinoma May Differ Among Hospital Types in the United States, a Report from the National Cancer Data Base
por: Reid-Lombardo, Kaye M., et al.
Publicado: (2007)

Is endoscopic ultrasound examination necessary in the management of esophageal cancer?
por: DaVee, Tomas, et al.
Publicado: (2017)

Meta-Enrichment Analyses to Identify Advanced Gastric Cancer Patients Who Achieve a Higher Response to S-1/Cisplatin
por: Takeuchi, Madoka, et al.
Publicado: (2019)

Medical management of gastric cancer: a 2017 update
por: Charalampakis, Nikolaos, et al.
Publicado: (2017)

Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases
por: Zhao, Shuangtao, et al.
Publicado: (2023)

Recent advances in targeted therapy for pancreatic adenocarcinoma
por: Fang, Yu-Ting, et al.
Publicado: (2023)

Evolution of gastric surgery techniques and outcomes
por: Shiozaki, Hironori, et al.
Publicado: (2016)

Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management
por: Gupta, Nikhil, et al.
Publicado: (2021)

GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2022)

Endoscopic management of esophageal cancer
por: Ahmed, Osman, et al.
Publicado: (2019)

Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma
por: Gu, Jianchun, et al.
Publicado: (2018)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

Recent advances in gastric cancer early diagnosis
por: Necula, Laura, et al.
Publicado: (2019)

Recent advances in precision medicine for pancreatic ductal adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

Clinically conserved genomic subtypes of gastric adenocarcinoma
por: Jeong, Yun Seong, et al.
Publicado: (2023)

Recent advances in the management of liposarcoma
por: Nassif, Nadar A., et al.
Publicado: (2016)

The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nrdknli5h9p6fhu8asuh4070q6